2023 Q1 Form 10-K Financial Statement

#000151655123000038 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.915M $1.540M $6.095M
YoY Change 18.05% 14.26% 23.97%
% of Gross Profit
Research & Development $1.185M $1.537M $6.012M
YoY Change -6.38% 38.07% 105.08%
% of Gross Profit
Depreciation & Amortization $33.17K $31.53K $115.0K
YoY Change 22.97% 27.55% 236.93%
% of Gross Profit
Operating Expenses $3.100M $3.078M $18.31M
YoY Change 7.35% 25.03% 133.34%
Operating Profit -$3.100M -$18.31M
YoY Change 7.35% 133.34%
Interest Expense $18.40K -$150.5K $665.1K
YoY Change -90.76% 197.06% -13.52%
% of Operating Profit
Other Income/Expense, Net -$2.067M -$456.5K -$1.163M
YoY Change 1230.54% 72.99%
Pretax Income -$5.168M -$9.890M -$19.47M
YoY Change 69.79% 293.66% 128.58%
Income Tax $0.00 $1.600K $6.741K
% Of Pretax Income
Net Earnings -$5.168M -$9.892M -$19.48M
YoY Change 69.79% 293.65% 128.6%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.04
Diluted Earnings Per Share -$0.01 -$0.01 -$0.04
COMMON SHARES
Basic Shares Outstanding 971.5M shares 912.2M shares 555.3M shares
Diluted Shares Outstanding 941.9M shares 555.3M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.669M $1.245M $1.245M
YoY Change -55.57% -86.15% -86.15%
Cash & Equivalents $2.669M $1.249M
Short-Term Investments
Other Short-Term Assets $820.0K $412.0K $7.699M
YoY Change 647.16% 624.49% 1123.86%
Inventory
Prepaid Expenses $957.6K $850.4K
Receivables
Other Receivables
Total Short-Term Assets $4.451M $8.944M $8.944M
YoY Change -36.35% -6.95% -6.95%
LONG-TERM ASSETS
Property, Plant & Equipment $77.08K $87.85K $159.1K
YoY Change -4.56% 0.16% -32.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.309K $8.309K $8.310K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $136.0K $167.4K $167.4K
YoY Change -37.6% -31.13% -31.13%
TOTAL ASSETS
Total Short-Term Assets $4.451M $8.944M $8.944M
Total Long-Term Assets $136.0K $167.4K $167.4K
Total Assets $4.587M $9.111M $9.111M
YoY Change -36.39% -7.55% -7.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.224M $1.670M $1.795M
YoY Change 39.3% 85.99% 99.43%
Accrued Expenses $1.153M $752.3K $1.984M
YoY Change 113.33% 25.01% 102.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $55.45K
YoY Change
Long-Term Debt Due $0.00 $1.848M $1.848M
YoY Change -100.0% -6.41% -6.41%
Total Short-Term Liabilities $9.367M $12.12M $12.12M
YoY Change 124.01% 209.78% 209.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.367M $12.12M $12.12M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $9.367M $12.12M $12.12M
YoY Change 121.06% 203.67% 203.67%
SHAREHOLDERS EQUITY
Retained Earnings -$71.91M -$66.74M
YoY Change 42.95% 41.23%
Common Stock $67.12M $63.73M
YoY Change 26.0% 19.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.781M -$3.008M -$3.008M
YoY Change
Total Liabilities & Shareholders Equity $4.587M $9.111M $9.111M
YoY Change -36.39% -7.55% -7.55%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.168M -$9.892M -$19.48M
YoY Change 69.79% 293.65% 128.6%
Depreciation, Depletion And Amortization $33.17K $31.53K $115.0K
YoY Change 22.97% 27.55% 236.93%
Cash From Operating Activities -$4.061M -$4.872M -$12.74M
YoY Change 39.32% 147.43% 96.82%
INVESTING ACTIVITIES
Capital Expenditures $1.860K -$357.6K $28.06K
YoY Change -6.95% 561.71% -69.12%
Acquisitions
YoY Change
Other Investing Activities $5.532M $5.309M $5.309M
YoY Change
Cash From Investing Activities $5.530M $5.667M $5.214M
YoY Change -276758.63% -10585.77% -5838.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$45.31K 34.17K -$208.8K
YoY Change -23.55% -140.81% -101.6%
NET CHANGE
Cash From Operating Activities -$4.061M -4.872M -$12.74M
Cash From Investing Activities $5.530M 5.667M $5.214M
Cash From Financing Activities -$45.31K 34.17K -$208.8K
Net Change In Cash $1.424M 829.2K -$7.738M
YoY Change -147.85% -139.36% -218.8%
FREE CASH FLOW
Cash From Operating Activities -$4.061M -$4.872M -$12.74M
Capital Expenditures $1.860K -$357.6K $28.06K
Free Cash Flow -$4.063M -$4.514M -$12.77M
YoY Change 39.29% 135.74% 94.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001516551
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.001
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
17357379 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
971549608 shares
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2021 dei Auditor Firm
AuditorFirmId
199
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
East Hanover, New Jersey
CY2021 dei Auditor Name
AuditorName
Mayer Hoffman McCann P.C.
CY2021 dei Auditor Location
AuditorLocation
Irvine, California
CY2022Q4 us-gaap Cash
Cash
1244527 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4580 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
850377 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
13432 usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
56870 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
9612097 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87710 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
146972 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8309 usd
CY2021Q4 us-gaap Assets
Assets
9855088 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1669997 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
897880 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
124901 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
2130 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9111072 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9855088 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6011805 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2931437 usd
CY2022Q4 skye Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
15814 usd
CY2021Q4 skye Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
174911 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
657734 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1422442 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
375842 usd
CY2022Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
95850 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
59732 usd
CY2021Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
0 usd
CY2021Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
450000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
487668 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0 usd
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1927 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1848375 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1524905 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
78700 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
82372 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12119126 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3912222 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78700 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12119126 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3990922 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
913528958 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
913528958 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
476108445 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
476108445 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
913528 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
476108 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
62816183 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
52644221 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66737765 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47256163 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3008054 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5864166 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6094617 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4916277 usd
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-6205310 usd
CY2021 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
18311732 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
7847714 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
117953 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
19011 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
3 usd
CY2022 skye Finance Charge
FinanceCharge
120228 usd
CY2021 skye Finance Charge
FinanceCharge
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629032 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
869206 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-59729 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21165 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
489595 usd
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
593802 usd
CY2022 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
6205310 usd
CY2021 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
117953 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
16396 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
364083 usd
CY2022 skye Increase Decrease In Prepaid Expenses Due From Related Parties
IncreaseDecreaseInPrepaidExpensesDueFromRelatedParties
-13432 usd
CY2021 skye Increase Decrease In Prepaid Expenses Due From Related Parties
IncreaseDecreaseInPrepaidExpensesDueFromRelatedParties
13432 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-112907 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
56595 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
8309 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
688269 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
533540 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
111471 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-14902 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-159097 usd
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
130824 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
313284 usd
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
282903 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1839252 usd
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
166531 usd
CY2022 us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
95850 usd
CY2021 us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
0 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-82372 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-9534 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12744072 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6474888 usd
CY2022 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
-66458 usd
CY2021 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28060 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
90866 usd
CY2022 us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
1475144 usd
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
5308913 usd
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5214395 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90866 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
935260 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6062774 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6999999 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1967 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11800 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4783 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
275537 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
680901 usd
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
616125 usd
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-208794 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13079356 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7738471 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6513602 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8987578 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2473976 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1249107 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8987578 usd
CY2022Q4 us-gaap Cash
Cash
1244527 usd
CY2021Q4 us-gaap Cash
Cash
8983007 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4580 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4571 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1249107 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
333547 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
44087 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
6741 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
1600 usd
CY2022 skye Asset Acquisition Costs Incurred But Not Yet Paid
AssetAcquisitionCostsIncurredButNotYetPaid
22471 usd
CY2021 skye Asset Acquisition Costs Incurred But Not Yet Paid
AssetAcquisitionCostsIncurredButNotYetPaid
170606 usd
CY2022 skye Accrued Financing Charges
AccruedFinancingCharges
11300 usd
CY2021 skye Accrued Financing Charges
AccruedFinancingCharges
0 usd
CY2022 skye Financing Of Insurance Premium
FinancingOfInsurancePremium
275537 usd
CY2021 skye Financing Of Insurance Premium
FinancingOfInsurancePremium
0 usd
CY2022 skye Establishment Of Right Of Use Asset
EstablishmentOfRightOfUseAsset
13000 usd
CY2021 skye Establishment Of Right Of Use Asset
EstablishmentOfRightOfUseAsset
0 usd
CY2022 skye Exercise Of Warrants
ExerciseOfWarrants
102857 usd
CY2021 skye Exercise Of Warrants
ExerciseOfWarrants
0 usd
CY2022 skye Stock Issued For Assets Net Of Equity Issuance Costs
StockIssuedForAssetsNetOfEquityIssuanceCosts
3074098 usd
CY2021 skye Stock Issued For Assets Net Of Equity Issuance Costs
StockIssuedForAssetsNetOfEquityIssuanceCosts
0 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
450786 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
856206 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
935260 usd
CY2021 skye Stock Issued During Period Value Common Stock And Warrants
StockIssuedDuringPeriodValueCommonStockAndWarrants
6062774 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4783 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8522182 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5864166 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
629032 usd
CY2022 skye Payments Of Stock Issuance Costs Other
PaymentsOfStockIssuanceCostsOther
25511 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
9858155 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
120228 usd
CY2022Q4 skye Working Capital Earnings Deficit
WorkingCapitalEarningsDeficit
-3175408 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66737765 usd
CY2022Q4 us-gaap Cash
Cash
1244527 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-18311732 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7847714 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-19481602 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8522182 usd
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
6205310 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates and judgments as to the appropriate carrying values of equity instruments, debt with embedded features, estimates related to the Company's estimation of the percentage of completion under its research and development contracts, contingent legal liabilities, fair value of assets acquired in the Acquisition, and the valuation of stock based compensation awards, which are not readily apparent from other sources.</span></div>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
25842 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 skye Research And Development Licensed Technology Costs Capitalized To Date
ResearchAndDevelopmentLicensedTechnologyCostsCapitalizedToDate
0 usd
CY2022 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
63717 usd
CY2021 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
6684 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3352 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2238 usd
CY2022Q4 skye Prepaid Clinical Expenses
PrepaidClinicalExpenses
646072 usd
CY2021Q4 skye Prepaid Clinical Expenses
PrepaidClinicalExpenses
470286 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
204305 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
83931 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
850377 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
554217 usd
CY2022 skye Class Of Warrant Or Right Warrants Vested And Outstanding
ClassOfWarrantOrRightWarrantsVestedAndOutstanding
197134632 shares
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
59732 usd
CY2022 skye Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
0 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-59729 usd
CY2022 skye Reclassification Of Derivatives To Equity
ReclassificationOfDerivativesToEquity
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3 usd
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
38567 usd
CY2021 skye Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
0 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21165 usd
CY2021 skye Reclassification Of Derivatives To Equity
ReclassificationOfDerivativesToEquity
0 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
59732 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4783 usd
CY2022 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
169640 usd
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
174911 usd
CY2022 skye Interest Expense Insurance Premium
InterestExpenseInsurancePremium
5896 usd
CY2021 skye Interest Expense Insurance Premium
InterestExpenseInsurancePremium
0 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
446 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
488238 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
592154 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1359 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1648 usd
CY2022 us-gaap Interest Expense
InterestExpense
665133 usd
CY2021 us-gaap Interest Expense
InterestExpense
769159 usd
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
289731589 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
213540505 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
150000 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
416270514 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1333333 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000000 usd
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.04
CY2022Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
73368 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
608199 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
869206 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
964853 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M21D
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-19481602 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19481602 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
555270089 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8522182 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8522182 usd
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
406599390 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-18801570 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-8446034 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-673291 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-74048 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19474861 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8520082 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6741 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2100 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6741 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2100 usd
CY2022Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
756 usd
CY2021Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
441 usd
CY2022Q4 skye Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
61 usd
CY2021Q4 skye Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
109 usd
CY2022Q4 skye Deferred Tax Assets Research And Development Credits
DeferredTaxAssetsResearchAndDevelopmentCredits
1199256 usd
CY2021Q4 skye Deferred Tax Assets Research And Development Credits
DeferredTaxAssetsResearchAndDevelopmentCredits
138581 usd
CY2022Q4 skye Deferred Tax Assets Sr And Ed Credits
DeferredTaxAssetsSRAndEDCredits
1000777 usd
CY2021Q4 skye Deferred Tax Assets Sr And Ed Credits
DeferredTaxAssetsSRAndEDCredits
0 usd
CY2022Q4 skye Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
16565 usd
CY2021Q4 skye Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
33906 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
1306097 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
8824896 usd
CY2021Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30648168 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8887647 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
975897 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
446623 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43972473 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9507307 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43957489 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9373577 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
14984 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
133730 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
14984 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
30939 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
0 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
102791 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
14984 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
133730 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4089720 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1789217 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-749744 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-475287 usd
CY2022 skye Effective Income Tax Rate Reconciliation Nondeductible Expense Change In Fair Value Of Warrant
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrant
-76672 usd
CY2021 skye Effective Income Tax Rate Reconciliation Nondeductible Expense Change In Fair Value Of Warrant
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrant
4445 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-892837 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1783362 usd
CY2022 skye Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount
884911 usd
CY2021 skye Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount
557016 usd
CY2022 skye Effective Income Tax Rate Reconciliation Change In Derivative Amount
EffectiveIncomeTaxRateReconciliationChangeInDerivativeAmount
4974768 usd
CY2021 skye Effective Income Tax Rate Reconciliation Change In Derivative Amount
EffectiveIncomeTaxRateReconciliationChangeInDerivativeAmount
0 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
35624 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
36731 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
69754 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
31863 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
281709 usd
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
168514 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
785 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
132366 usd
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
20916 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6741 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
34583912 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1784626 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1134173 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1087413 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
687598 usd
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
19 usd
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
37145 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2872020 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1784626 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2022Q4 skye Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
40597 usd
CY2021Q4 skye Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
140953 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
227350 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133537 usd
CY2022Q4 skye Insurance Loan Payable Current
InsuranceLoanPayableCurrent
55451 usd
CY2021Q4 skye Insurance Loan Payable Current
InsuranceLoanPayableCurrent
0 usd
CY2022Q4 skye Accrued Board Fees Current
AccruedBoardFeesCurrent
0 usd
CY2021Q4 skye Accrued Board Fees Current
AccruedBoardFeesCurrent
44984 usd
CY2022Q4 skye Deposit From Divestment
DepositFromDivestment
553800 usd
CY2021Q4 skye Deposit From Divestment
DepositFromDivestment
0 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
134896 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
410348 usd
CY2021Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
56368 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1422442 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
375842 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
90701 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M29D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
83093 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
83093 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4393 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
78700 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
78700 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
82372 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78700 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
78700 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
161072 usd

Files In Submission

Name View Source Status
skye-20221231_pre.xml Edgar Link unprocessable
0001516551-23-000038-index-headers.html Edgar Link pending
0001516551-23-000038-index.html Edgar Link pending
0001516551-23-000038.txt Edgar Link pending
0001516551-23-000038-xbrl.zip Edgar Link pending
a2022formofwarrantissuedto.htm Edgar Link pending
consentofmarcumllp-ex231.htm Edgar Link pending
consentofmhm-ex232.htm Edgar Link pending
descriptionoftheregistrant.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skye-20221231.htm Edgar Link pending
skye-20221231.xsd Edgar Link pending
skye-20221231xex311.htm Edgar Link pending
skye-20221231xex312.htm Edgar Link pending
skye-20221231xex321.htm Edgar Link pending
skye-20221231xex322.htm Edgar Link pending
subsidiariesoftheregistran.htm Edgar Link pending
skye-20221231_def.xml Edgar Link unprocessable
skye-20221231_lab.xml Edgar Link unprocessable
skye-20221231_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
skye-20221231_cal.xml Edgar Link unprocessable